| Tarakjian, Denis |
NCT05264506: Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive |
|
|
| Terminated | 3 | 2007 | US | NOMAC-E2 COC, Nomegestrol acetate / estradiol | Organon and Co, IQVIA Inc., OSTAtistics | Contraception | 01/24 | 01/24 | | |
SIS, NCT06597344: A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis) |
|
|
| Recruiting | 3 | 90 | US | Gepotidacin | GlaxoSmithKline | Urinary Tract Infections | 03/25 | 03/25 | | |
NCT04457076: Evaluation of the Efficacy, Safety, and Tolerability of LevoCept |
|
|
| Not yet recruiting | 3 | 1525 | US | LevoCept | Sebela Women's Health Inc., PRA Health Sciences | Contraception, Women at Risk for Pregnancy | 01/29 | 01/31 | | |
NCT01429389: Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy |
|
|
| Recruiting | N/A | 2000 | Canada, US | | Sequenom, Inc. | Down Syndrome, Fetal Aneuploidy | 12/25 | 03/26 | | |
| Guidotti, Seline |
NCT05139121: Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles |
|
|
| Completed | 3 | 1319 | Canada, US | MR-100A-01, Transdermal contraceptive delivery system | Mylan Technologies Inc., Mylan Inc. | Contraception | 01/25 | 01/25 | | |
NCT04457076: Evaluation of the Efficacy, Safety, and Tolerability of LevoCept |
|
|
| Not yet recruiting | 3 | 1525 | US | LevoCept | Sebela Women's Health Inc., PRA Health Sciences | Contraception, Women at Risk for Pregnancy | 01/29 | 01/31 | | |
| Fleet, Merrilee |
NCT04457076: Evaluation of the Efficacy, Safety, and Tolerability of LevoCept |
|
|
| Not yet recruiting | 3 | 1525 | US | LevoCept | Sebela Women's Health Inc., PRA Health Sciences | Contraception, Women at Risk for Pregnancy | 01/29 | 01/31 | | |
